Valuation: Mega Lifesciences

Market Cap 32.91B 979M 855M 789M 727M 1.37B 94.25B 1.4B 9.43B 3.71B 46.16B 3.68B 3.59B 159B P/E 2026 *
14.2x
P/E 2027 * 13.4x
Enterprise Value 28.3B 842M 735M 679M 626M 1.18B 81.04B 1.21B 8.11B 3.19B 39.69B 3.16B 3.09B 137B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.8x
Free-Float
38.61%
Yield 2026 *
4.63%
Yield 2027 * 4.97%
1 day-0.66%
1 week+2.03%
Current month+2.72%
1 month+7.09%
3 months+14.39%
6 months+7.09%
Current year+12.69%
1 week 36.75
Extreme 36.75
38.5
1 month 34
Extreme 34
38.5
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 15.9
Extreme 15.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 31/12/1987
Director of Finance/CFO 61 31/12/1996
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 31/12/1997
Director/Board Member 64 31/12/2012
Director/Board Member 73 31/01/2013
Date Insider Type Main position Quantity % Market Cap.
29/04/25 Buy

Chief Executive Officer

100,000 0.0115%
28/04/25 Buy

Chief Executive Officer

150,000 0.0172%
28/04/25 Buy

Chief Executive Officer

150,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%+2.03%+34.82%-3.82% 987M
+0.85%-0.80%+54.84%+163.70% 1,043B
+1.23%-1.53%+55.26%+59.07% 602B
+0.04%+2.58%+32.96%+88.75% 449B
+0.78%-0.71%+30.04%+24.61% 327B
+1.41%+0.58%+33.92%+47.20% 279B
-0.27%-1.87%+22.13%+23.47% 264B
-1.76%+2.37%-22.19%-38.45% 227B
-1.42%+0.80%+22.81%+60.77% 201B
-1.48%+3.43%+23.42%+73.31% 169B
Average -0.17%+0.68%+28.80%+49.86% 356.22B
Weighted average by Cap. +0.21%+0.04%+37.59%+81.23%

Financials

2026 *2027 *
Net sales 14.88B 442M 387M 357M 329M 620M 42.6B 633M 4.26B 1.68B 20.86B 1.66B 1.62B 71.82B 15.61B 464M 406M 374M 345M 650M 44.7B 665M 4.47B 1.76B 21.89B 1.74B 1.71B 75.37B
Net income 2.32B 68.98M 60.29M 55.63M 51.28M 96.65M 6.64B 98.79M 665M 262M 3.25B 259M 253M 11.2B 2.46B 73.14M 63.92M 58.98M 54.37M 102M 7.04B 105M 705M 277M 3.45B 275M 269M 11.88B
Net Debt -4.61B -137M -120M -111M -102M -192M -13.21B -196M -1.32B -520M -6.47B -515M -504M -22.27B -4.76B -141M -124M -114M -105M -198M -13.62B -203M -1.36B -536M -6.67B -531M -519M -22.96B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
17/07/26 THB 37.75 -0.66% 575,076
16/07/26 THB 38.00 0.00% 211,213
15/07/26 THB 38.00 +0.66% 873,912
14/07/26 THB 37.75 +1.34% 737,163
13/07/26 THB 37.25 +0.68% 700,210
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
37.75THB
Average target price
41.14THB
Spread / Average Target
+8.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock